Fidelis Diagnostics Partners with Exalenz Bioscience to Add H. pylori Breath Testing Solutions to Its Portfolio of ServicesAugust 7, 2012 9:00 am | by The Associated Press | News | Comments
LOS ANGELES--(BUSINESS WIRE)--Aug 7, 2012--Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, today announced it has entered into a strategic partnership with Exalenz Bioscience, Inc., a medical device company specializing in the...
Endomagnetics, the company known for developing magnetic technology for use in breast cancer staging, has been awarded government funding to extend its application to another form of cancer. The project will explore the clinical feasibility of applying magnetic sentinel lymph node (SLN) detection to melanoma...
Groundbreaking report in Mayo Clinic Proceedings examines the implications of the Accountable Care Organization component of the Patient Protection and Affordable Care Act
Gen-Probe's products include tests for sexually transmitted diseases. Hologic expects the deal to deepen its women's health focus and make it a major provider of STD diagnostics.
Medicare's war on fraud is going high-tech with the opening of a $3.6 million command center that features a giant screen and the latest computer and communications gear.
Bias may be completely unintentional, but everyone has it to one degree or another. It is the responsibility of ethical scientists to acknowledge those biases so that research data can be viewed more accurately and science is not slanted.
Medical devices save countless lives, but an interdisciplinary research team warns that federal regulators need to improve how they track security and privacy problems in medical devices.
A technique, known as photoacoustics, can find some forms of melanoma even if only a few cancerous cells exist, but a recent study by MU researchers found that the technique was limited in its ability to identify other types of cancer.
Two new targets have been discovered for antiviral therapies and vaccines strategies that could enhance the body's defenses against such infectious diseases as West Nile and hepatitis C.
The patents cover the technology in Arradiance’s GEM-R2 and GEM-R2D2 nanofilms that functionalize bare detector substrates of any size or insulating material to enable noiseless, low signal amplification.
Genetic test maker 23andMe is asking the FDA to approve its personalized DNA test in a move that, if successful, could boost acceptance of technology that is viewed skeptically by leading scientists who question its usefulness.
A tiny vibrating cantilever sensor could soon help doctors and field clinicians quickly detect harmful toxins, bacteria and even indicators of certain types of cancer from small samples of blood or urine.
Six more patients suspected to have Ebola have been admitted to the hospital days after investigators confirmed an outbreak of the highly infectious disease in a remote corner of western Uganda, a health official said on Monday.
Medical and industrial equipment maker Roper Industries is buying hospital software company Sunquest Information Systems for approximately $1.42 billion.
DSM, a global leader in biomedical materials, today announced that its VitroStealth® non-biofouling coating is used in Afinion®, Axis-Shield’s next generation point-of-care diagnostic system. Physicians can use Afinion® during the span of an office visit and obtain patient lipid levels within a matter of minutes.
Epilepsy Organizations Award Funding for New Devices to Treat, Detect, and Monitor Epilepsy ConditionsJune 25, 2012 6:45 am | News | Comments
The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of their New Therapy Grants Program, a unique joint venture of the two non-profit epilepsy organizations to advance clinical development...
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the launch of its Nellcor™ SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform.
PositiveID Corporation Wins Gold at Connected World Value Chain Awards for Its iglucose Mobile Health Solution for Diabetes ManagementJune 19, 2012 6:50 am | News | Comments
PositiveID Corporation announced it has won the Gold award for its iglucose mobile health solution for diabetes management at Connected World magazine's Value Chain Awards in the Home Health category.
Dexcom, Inc. today announced that it has received CE Mark approval for its fourth generation continuous glucose monitoring system, the Dexcom G4® system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America...
A powerful color-based imaging technique is making the jump from remote sensing to the operating room—and a team of scientists* at the National Institute of Standards and Technology (NIST) have taken steps to ensure it performs...
German Drazer, an assistant professor of chemical and biomolecular engineering, and his doctoral student, Jorge A. Bernate, reported that they have developed a lab-on-chip platform...
A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS) together with clinicians from Boston's Brigham and Women's Hospital (BWH) have identified a unique set of cells in the cervix that are the cause...
A similar design could lead to chips that detect drug-resistant strains of HIV and tuberculosis.
Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX Advance Model 8004CB Series Sensor for Neonatal, Pediatric PatientsJune 8, 2012 7:33 am | News | Comments
Nonin Medical, Inc. announced today the U.S. market release of its EQUANOX™ Advance Model 8004CB Series neonatal/pediatric sensor. The EQUANOX Advance 8004CB Series Sensor with Nonin's patent-pending Dynamic Compensation™ algorithm...
Welldoc’s Mobile Diabetes Intervention System Highlighted at American Diabetes Association 72nd Scientific SessionsJune 8, 2012 7:30 am | News | Comments
WellDoc, a healthcare behavioral science and technology company whose products improve the lives of people with chronic diseases, today released new data from a study first published last fall in Diabetes Care.